-
Midecamycin: From MIC Data to Assay Insight
2026-08-21
Midecamycin is an acetoxy-substituted macrolide antibiotic whose value extends beyond simple growth inhibition. This evidence-led guide explains how its ribosomal mechanism, organism-specific MIC profile, and resistance limitations should shape modern microbiology assays.
-
DiscoveryProbe Protease Inhibitor Library: Assay Logic
2026-08-20
The DiscoveryProbe™ Protease Inhibitor Library supports protease inhibition studies from biochemical screening to cell-based mechanism testing. This article explains how to use assay architecture, precursor biology, orthogonal readouts, and hit triage to extract more meaningful data from protease screens.
-
Reporter mRNA as a Translational Control
2026-08-20
Firefly Luciferase mRNA can function as more than a routine reporter: it provides a mechanistically interpretable control for delivery, translation, formulation, and repeat-dose studies. This article explains how ARCA capping and modified nucleotides support assay reliability, and how reporter data can inform—but not replace—immune-memory and translational evaluations.
-
Novobiocin Sodium: DNA Replication Workflows
2026-08-19
Novobiocin Sodium enables staged inhibition of bacterial DNA replication while preserving morphology, membrane, and recovery readouts. This guide translates protoplast evidence into practical workflows for cell cycle and DNA damage studies, antibiotic resistance research, and carefully bounded exploratory pathway assays.
-
ML385 Workflow for NRF2 and Ferroptosis Research
2026-08-19
ML385 provides a practical way to test whether NRF2 activity drives antioxidant defense, ferroptosis sensitivity, or therapeutic resistance. This workflow connects concentration–time optimization with orthogonal molecular, biochemical, and functional readouts for cancer and oxidative-stress studies.
-
Carcinogen-Induced seRNA Drives NPC Metastasis
2026-08-18
The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a regulator of nasopharyngeal carcinoma metastasis. Its mechanistic model connects enhancer–promoter looping and R-loop formation with an NPM1/c-Myc/NDRG1 transcriptional axis, providing a framework for studying how environmental exposures reshape metastatic gene regulation.
-
Oral Faropenem Sodium and AMR Risk
2026-08-18
The reference article interprets oral faropenem as a penem antibiotic whose convenience and broad β-lactam activity may encourage inappropriate prescribing and contribute to cross-resistance with reserve carbapenems. Its main contribution is a stewardship-focused synthesis linking regulatory status, consumption trends, antimicrobial spectrum, and the need for laboratory-supported use rather than presenting new clinical trial data.
-
ROS-Responsive LNPs for Mutant RAS mRNA Therapy
2026-08-17
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to improve mRNA release selectively in tumor cells. The lead lipid, BAmP-TK-12, delivered DUF5-encoding mRNA, depleted mutant RAS, and produced stronger antitumor activity than a small-molecule RAS inhibitor in the reported models.
-
TNF-alpha recombinant murine protein for Cell Assays
2026-08-17
Learn how TNF-alpha recombinant murine protein, SKU P1002, can improve the interpretation and reproducibility of murine cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects cytokine-driven apoptosis with recent evidence on transcription-independent cell death and provides practical handling, optimization, and vendor-selection guidance.
-
CBD in Orofacial Inflammatory Pain: Mechanisms
2026-08-16
This 2026 study shows that cannabidiol (CBD) can reduce both nociceptive and pain-related affective abnormalities in mouse models of orofacial and chronic inflammatory pain. Its main innovation is the integration of peripheral CB2 signaling, central CB1 pathways, inflammatory and oxidative measurements, and serotonin activity to explain how one intervention influences sensory, emotional, and cognitive pain dimensions.
-
SM-164 and the Logic of Cell-Death Assays
2026-08-15
SM-164 is a bivalent Smac mimetic that exposes how IAP control, TNFα signaling, and higher-order death assemblies shape tumor-cell fate. This article translates necrosome stoichiometry research into a branch-resolved framework for cancer research and apoptosis assays.
-
NEDD4L–PRMT5 Control of Colorectal Liver Metastasis
2026-08-14
The reference study identifies NEDD4L as an E3 ubiquitin ligase that restrains colorectal cancer liver metastasis by targeting PRMT5 for degradation. Its in vivo loss-of-function screen and mechanistic validation connect the NEDD4L–PRMT5 axis to AKT1 arginine methylation and AKT/mTOR signaling, providing a framework for studying ubiquitin-dependent control of metastatic colonization.
-
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-14
A 2024 study identifies Moxidectin as a potentiator of amphotericin B and nystatin against Candida albicans, linking synergy to increased fungal ergosterol biosynthesis and polyene binding. The work supports a preclinical strategy for improving polyene activity in oral candidiasis while highlighting the need for pharmacological and safety validation.
-
Capecitabine for Reliable Viability Assays
2026-08-13
Learn how Capecitabine (SKU A8647) can improve interpretation of viability, proliferation, and cytotoxicity assays across monolayer, organoid, and tumor–stroma models. This scenario-based guide covers prodrug biology, assay design, stock preparation, data interpretation, and practical vendor-selection criteria.
-
Linoleic Acid (C18:2) Workflow Guide
2026-08-13
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a practical reagent for studying membrane behavior, oxidative stress, erythrocyte injury, epithelial migration, and essential fatty acid deficiency. Because it is water-insoluble and solution stability is limited, it should be prepared in a compatible organic solvent immediately before use rather than applied from long-term aqueous or aged stocks.